These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10087889)

  • 1. [A case of ulcerative colitis associated with interstitial pneumonitis during administration of 5-aminosalicylic acid].
    Ogino H; Tachibana Y; Yonejima H; Satomura Y; Unoura M; Miwa A
    Nihon Shokakibyo Gakkai Zasshi; 1999 Feb; 96(2):164-9. PubMed ID: 10087889
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interstitial pneumonia related to mesalamine].
    Lamsiah T; Moudden K; Baaj M; Hadri L
    Gastroenterol Clin Biol; 2010 Mar; 34(3):224-6. PubMed ID: 20299168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mesalazine-induced intersticial pneumonitis in patients with ulcerative colitis].
    Prado Mel E; Gil López M
    Farm Hosp; 2016 Jan; 40(1):55-7. PubMed ID: 26882835
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations.
    Foster RA; Zander DS; Mergo PJ; Valentine JF
    Inflamm Bowel Dis; 2003 Sep; 9(5):308-15. PubMed ID: 14555914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute respiratory failure secondary to mesalamine-induced interstitial pneumonitis.
    Abraham A; Karakurum A
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23964037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesalazine induced interstitial pneumonitis in the COVID era.
    Aparicio Serrano A; Gallego Jiménez E; Castro Rodríguez J; Soto Escribano P; Iglesias Flores E; Marín Pedrosa S; Benítez JM
    Rev Esp Enferm Dig; 2022 Jul; 114(7):429-430. PubMed ID: 35199533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesalamine-induced lung injury in a patient with ulcerative colitis and a confounding autoimmune background: a case report.
    Actis GC; Ottobrelli A; Baldi S; Scappaticci E; Modena V; Fusaro E; Mengozzi G; Rizzetto M
    Mt Sinai J Med; 2005 Mar; 72(2):136-40. PubMed ID: 15770345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pancreatitis secondary to long-term 5- aminosalicylic acid therapy in a patient with ulcerative colitis: a case-report.
    Ouakaa-Kchaou A; Gargouri D; Kochlef A; Bibani N; Elloumi H; Trad D; Kharrat J
    Tunis Med; 2014 Jun; 92(6):423. PubMed ID: 25741849
    [No Abstract]   [Full Text] [Related]  

  • 9. What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?
    Riley SA
    Gut; 1998 Jun; 42(6):761-3. PubMed ID: 9691909
    [No Abstract]   [Full Text] [Related]  

  • 10. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
    Murphy SJ; Mayer L; Abreu MT
    J Clin Gastroenterol; 2011 Jan; 45(1):83-4. PubMed ID: 20535023
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interstitial nephritis after treatment with mesalazine in the patient with ulcerative colitis].
    Maeda S; Nomura S; Tahara M; Haneda M; Kikkawa R
    Nihon Naika Gakkai Zasshi; 2001 May; 90(5):872-3. PubMed ID: 11460356
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interstitial nephritis associated with mesalazine therapy].
    Vuotila M; Ikäheimo R; Pietiläinen T
    Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis.
    Adachi E; Okazaki K; Matsushima Y; Seno H; Uchida K; Nakase H; Kawanami C; Nakamura T; Chiba T
    Int J Pancreatol; 1999 Jun; 25(3):217-21. PubMed ID: 10453423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial pneumonitis due to mesalamine.
    Pascual-Lledó JF; Calvo-Bonachera J; Carrasco-Miras F; Sanchez-Martínez H
    Ann Pharmacother; 1997 Apr; 31(4):499. PubMed ID: 9101017
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pulmonary complications in patient with ulcerative colitis, treated with 5-aminosalicylic preparations].
    Radwan P; łupina T; Radwan-Kwiatek K; Milanowski J
    Pneumonol Alergol Pol; 2006; 74(2):224-6. PubMed ID: 17269374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pericardial effusion associated with mesalamine treatment in a patient with ulcerative colitis.
    Ezquerra A; Resina E; Montes Á; Álvarez-Malé T; P Gisbert J
    Gastroenterol Hepatol; 2021 Dec; 44(10):721-723. PubMed ID: 33190940
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein-losing gastropathy caused by mesalamine in a patient with ulcerative colitis.
    Kim JH; Moon W; Park SJ; Park MI; Kim SE; Ku KH; Song SE; Chang HK
    Turk J Gastroenterol; 2014 Aug; 25(4):444-5. PubMed ID: 25254535
    [No Abstract]   [Full Text] [Related]  

  • 19. The culprit of mesalamine intolerance: case series and literature review.
    Xie C; Quan R; Hong F; Zou K; Yan W; Fu Y
    BMC Gastroenterol; 2019 Jul; 19(1):138. PubMed ID: 31366329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic interstitial nephritis due to 5-aminosalicylic acid.
    Agharazii M; Marcotte J; Boucher D; Noël R; Lebel M
    Am J Nephrol; 1999; 19(3):373-6. PubMed ID: 10393373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.